Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
OncoSil Medical Ltd ( (AU:OSL) ) has shared an update.
OncoSil Medical Ltd, an ASX-listed oncology-focused medical company, develops and commercialises cancer treatment technologies and related medical devices.
The company has notified the cessation of 7,500 OSLAR options, which were due to expire in November 2028 with an exercise price of $12.00, after the conditional rights attached to these securities lapsed because the required conditions were not, or could no longer be, satisfied, resulting in a minor adjustment to the company’s issued capital structure.
The most recent analyst rating on (AU:OSL) stock is a Sell with a A$1.00 price target. To see the full list of analyst forecasts on OncoSil Medical Ltd stock, see the AU:OSL Stock Forecast page.
More about OncoSil Medical Ltd
OncoSil Medical Ltd is an ASX-listed medical company focused on cancer treatment technologies, developing and commercialising oncology-related medical devices and therapies.
Average Trading Volume: 21,112
Technical Sentiment Signal: Sell
Current Market Cap: A$17M
For detailed information about OSL stock, go to TipRanks’ Stock Analysis page.